Adaptive Biotechnologies

$41.83
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.53 (+3.78%) As of 6:02 PM UTC today

Why Robinhood?

You can buy or sell ADPT and other stocks, options, and ETFs commission-free!

About ADPT

Adaptive Biotechnologies Corp. engages in the development of an immune medicine platform. It harnesses the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease.

CEO
Chad Robins
Employees
622
Headquarters
Seattle, Washington
Founded
2009
Market Cap
6.06B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
1.04M
High Today
$41.90
Low Today
$39.38
Open Price
$39.91
Volume
301.36K
52 Week High
$71.25
52 Week Low
$28.00

ADPT Earnings

-$0.33
-$0.22
-$0.11
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Available May 5, After Hours

You May Also Like

CALX
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure